News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
95,533 Results
Type
Article (3084)
Company Profile (24)
Press Release (92425)
Multimedia
Podcasts (5)
Webinars (2)
Section
Business (27316)
Career Advice (189)
Deals (9031)
Drug Development (9835)
Employer Resources (5)
FDA (1895)
Job Trends (2256)
News (48289)
Policy (3447)
Tag
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
Academia (371)
Adcomms (2)
Allergies (3)
Alliances (7619)
ALS (17)
Alzheimer's disease (413)
Antibody-drug conjugate (ADC) (8)
Approvals (1912)
Artificial intelligence (22)
Autoimmune disease (1)
Automation (4)
Bankruptcy (96)
Best Places to Work (2059)
Biosimilars (11)
Biotechnology (18)
Bladder cancer (7)
Brain cancer (7)
Breast cancer (20)
Cancer (251)
Cardiovascular disease (10)
Career advice (158)
Career pathing (3)
CAR-T (11)
Cell therapy (37)
Cervical cancer (2)
Clinical research (8111)
Collaboration (108)
Compensation (36)
Complete response letters (1)
COVID-19 (142)
C-suite (42)
Cystic fibrosis (10)
Data (314)
Depression (29)
Diabetes (22)
Diagnostics (773)
Digital health (3)
Diversity, equity & inclusion (2)
Drug discovery (10)
Drug pricing (2)
Duchenne muscular dystrophy (9)
Earnings (8831)
Editorial (5)
Employer branding (2)
Employer resources (5)
Events (13218)
Executive appointments (149)
FDA (2061)
Featured Employer (7)
Frontotemporal dementia (1)
Funding (124)
Gene editing (3)
Gene therapy (19)
GLP-1 (47)
Government (269)
Guidances (8)
Healthcare (2615)
Huntington's disease (4)
IgA nephropathy (1)
Immunology and inflammation (10)
Indications (3)
Infectious disease (152)
Inflammatory bowel disease (24)
Inflation Reduction Act (1)
Influenza (5)
Intellectual property (13)
Interviews (35)
IPO (5138)
IRA (1)
Job creations (303)
Job search strategy (136)
Layoffs (31)
Legal (994)
Liver cancer (4)
Lung cancer (40)
Lymphoma (13)
Management (1)
Manufacturing (24)
MASH (6)
Medical device (2102)
Medtech (2103)
Mergers & acquisitions (4165)
Metabolic disorders (51)
Multiple sclerosis (22)
NASH (1)
Neurodegenerative disease (24)
Neuropsychiatric disorders (12)
Neuroscience (619)
NextGen: Class of 2025 (1123)
Non-profit (390)
Northern California (350)
Now hiring (3)
Obesity (24)
Opinion (11)
Ovarian cancer (9)
Pain (16)
Pancreatic cancer (20)
Parkinson's disease (58)
Partnered (3)
Patents (45)
Patient recruitment (14)
Peanut (2)
People (9325)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase I (2348)
Phase II (3563)
Phase III (2888)
Pipeline (188)
Policy (5)
Postmarket research (277)
Preclinical (1074)
Press Release (1)
Prostate cancer (8)
Psychedelics (8)
Radiopharmaceuticals (51)
Rare diseases (42)
Real estate (672)
Recruiting (2)
Regulatory (2423)
Reports (5)
Research institute (366)
Resumes & cover letters (23)
Rett syndrome (2)
RSV (3)
Schizophrenia (43)
Series A (17)
Series B (11)
Sickle cell disease (9)
Southern California (467)
Special edition (3)
Spinal muscular atrophy (33)
Sponsored (1)
Startups (627)
State (1)
Stomach cancer (1)
Supply chain (6)
Tariffs (1)
The Weekly (5)
United States (4058)
Vaccines (33)
Venture capitalists (5)
Weight loss (5)
Date
Today (23)
Last 7 days (95)
Last 30 days (364)
Last 365 days (5387)
2025 (1565)
2024 (5971)
2023 (7105)
2022 (8541)
2021 (9901)
2020 (9218)
2019 (6646)
2018 (5133)
2017 (4977)
2016 (4292)
2015 (5731)
2014 (3959)
2013 (3135)
2012 (3253)
2011 (2885)
2010 (2578)
Location
Africa (39)
Alabama (2)
Arizona (26)
Arkansas (2)
Asia (5120)
Australia (646)
California (1016)
Canada (246)
China (56)
Colorado (29)
Connecticut (55)
Delaware (13)
Europe (8488)
Florida (200)
Georgia (24)
Idaho (9)
Illinois (126)
India (1)
Indiana (71)
Japan (18)
Kansas (19)
Kentucky (2)
Maine (39)
Maryland (135)
Massachusetts (677)
Michigan (62)
Minnesota (53)
Mississippi (2)
Missouri (11)
Montana (3)
Nebraska (4)
Nevada (25)
New Hampshire (11)
New Jersey (319)
New Mexico (3)
New York (399)
North Carolina (199)
Northern California (350)
Ohio (37)
Oregon (2)
Pennsylvania (251)
Rhode Island (4)
South America (89)
South Carolina (7)
Southern California (467)
Tennessee (26)
Texas (176)
Utah (46)
Virginia (27)
Washington D.C. (5)
Washington State (70)
West Virginia (1)
Wisconsin (13)
95,533 Results for "dart neuroscience llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
Alpha Tau Medical Ltd. announced today that its first patient with liver cancer metastases has been treated in a feasibility and safety study of Alpha DaRT at the McGill University Health Center in Montreal, Canada.
May 13, 2024
·
6 min read
Press Releases
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease
February 3, 2025
·
4 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Neurodegenerative disease
Denali Goes All In on Neuroscience’s Thorniest Hurdle: Crossing the Blood-Brain Barrier
After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, which today began a rolling BLA for accelerated approval.
April 2, 2025
·
5 min read
·
Dan Samorodnitsky
BioMidwest
Dermatology Association of Radiation Therapy (DART) Opposes Move to Cancel Medicare Coverage for Nonsurgical Treatment of Nonmelanoma Skin Cancer in Seven States
The Dermatology Association of Radiation Therapy (DART) filed comments in opposition to a proposed change in Medicare coverage in seven states of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for the treatment of nonmelanoma skin cancer (NMSC).
April 29, 2024
·
5 min read
Bio NC
Precision BioSciences to Present at Hep-DART 2023
Precision BioSciences, Inc. today announced that the company will present at Hep-DART 2023 in an industry session and host a poster presentation on December 5, 2023, in Los Cabos, Mexico.
November 30, 2023
·
1 min read
Press Releases
Alto Neuroscience to Participate in the JonesResearch Virtual CNS Day
April 22, 2025
·
1 min read
Press Releases
Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience
February 19, 2025
·
4 min read
Press Releases
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - April 25, 2025
April 28, 2025
·
3 min read
Press Releases
Unlearn and Trace Neuroscience Partner to Optimize ALS Clinical Trial
April 1, 2025
·
3 min read
1 of 9,554
Next
